Cadila Healthcare, a part of the Zydus Group, said its U.S. unit has agreed to acquire the assets of U.S.-based pharmaceutical company Nesher Pharmaceuticals Inc. for an undisclosed amount.

Shares of Cadila Healthcare Ltd jumped 7.9% on Monday after India last week approved the drugmaker's COVID-19 vaccine, the world's first DNA shot against the coronavirus, for emergency use in ...

South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare , the Indian drugmaker said on Wednesday.

As Cadila Healthcare's world-first DNA vaccine for Covid-19 was approved for emergency use in India, pharma tycoon Pankaj Patel's fortune rose to $6.2 billion.

Cadila Healthcare Ltd., an Indian drugmaker working to develop an indigenous coronavirus vaccine, said it expects to supply between 100 million to 150 million doses of its candidate this year.

Given the publicity that has come with FDA bans on a growing list of Indian facilities, even a report of an FDA shortfall at a plant can have consequences these days. That is where India's Cadila ...

Cadila Healthcare Ltd. plans to submit trial data for its Covid-19 vaccine by end of May and is looking for an approval in June, Financial Express reported citing Sharvil Patel, managing director ...

Zydus Cadila's needle-free coronavirus vaccine-- ZyCoV-D-- is likely to be available by early October. The vaccine has been approved to be administered to adolescents between ages 12 and 18.

The Cadila version, dubbed Exemptia, will cost a fifth of Humira's U.S. price at $200 a vial, Reuters reports. While that's still too expensive for most of India's population--70% of whom gets by ...